Consistent with CEP55 expression patterns, immunoblot and quantitative PCR assays validated elevated levels of ILF3 protein and mRNA in primary BC samples and in MDA-MB-231 and MCF-7 BC cells compared with their normal counterparts (Fig. 4B and E). This evidence concerns the gene ILF3 and breast cancer.